Sex-based differences in multiple sclerosis (MS): Part II: Rising incidence of multiple sclerosis in women and the vulnerability of men to progression of this disease

Current Topics in Behavioral Neurosciences

Volumn 26, Issue , 2015, Pages 57-86

  Dunn, Shannon E ^a,b   Gunde, Eva ^c   Lee, Hyunwoo ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Axon degeneration; Cognition; Environmental influence; Incidence; Magnetic resonance imaging; Multiple sclerosis; Neuroprotection; Pathology; Progression; Remyelination; Sex difference

Indexed keywords

ANDROSTANOLONE; CALCITRIOL; COLECALCIFEROL; SATURATED FATTY ACID; SEX HORMONE; TESTOSTERONE; TOLL LIKE RECEPTOR 7; VITAMIN D;

CENTRAL NERVOUS SYSTEM DISEASE; COGNITION; DISABILITY SEVERITY; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; FAT INTAKE; FEMALE; GRAY MATTER; HUMAN; HYGIENE HYPOTHESIS; INCIDENCE; LIFESTYLE MODIFICATION; LIGHT EXPOSURE; MALE; MONONUCLEOSIS; MULTIPLE SCLEROSIS; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; REMYELINIZATION; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW (TOPIC); ULTRAVIOLET RADIATION; URBANIZATION; WHITE MATTER; IMMUNOLOGY; PATHOLOGY; SEXUAL DEVELOPMENT;

DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MULTIPLE SCLEROSIS; SEX CHARACTERISTICS; SEX FACTORS;

EID: 84943622393     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2015_370     Document Type: Chapter

References (174)

1. Agranoff BW, Goldberg D (1974) Diet and the geographic distribution of multiple sclerosis. Lancet 2:1061-1066
2. Ahn JJ, O’Mahoney J, Moshkova M et al (2014) Influence of puberty in females on autoimmune risk: insights from studies in childhood onset multiple sclerosis and experimental autoimmune encephalomyelitis. Mult Scler, Dec 22 piii 13524585 14551453
3. Alkayed NJ, Harukuni I, Kimes AS et al (1998) Gender-linked brain injury in experimental stroke. Stroke 29:159-165
4. Alonso A, Hernan MA (2008) Temporal trends in the incidence of multiple sclerosis: a systemic review. Neurology 71:129-135
5. Alonso A, Jick SS, Olek MJ et al (2005) Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62:1362-1365
6. Alroughani R, Ahmed SF, Behbahani R et al (2014) Increasing prevalence and incidence rates of multiple sclerosis. Mult Scler 20:543-547
7. Antulov R, Weinstock-Guttman B, Cox JL et al (2009) Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler 15:345-354
8. Ascherio A, Munger KL (2007a) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61:288-299
9. Ascherio A, Munger KL (2007b) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61:504-513
10. Ascherio A, Munger KL, Lennette ET et al (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286:3083-3088
11. Ascherio A, Munger KL, Lunemann JD (2012) The initiation and prevention of multiple sclerosis. Nat Rev Neurol 8:602-612
12. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911-920
13. Barkhof F (1999) MRI in multiple sclerosis: correlation with expanded disability scale (EDSS). Mult Scler 5:283-286
14. Barkhof F, Held U, Simon JH et al (2005) Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials. Neurology 65:1447-1454
15. Beatty WW, Aupperle RL (2002) Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol 16:472-480
16. Benedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7:332-342
17. Berchtold NC, Cribbs DH, Coleman PD et al (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 105:15605-15610
18. Bjornevik K, Riise T, Casetta I et al (2014) Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study. Mult Scler 20:1042-1049
19. Bo L, Vedeler CA, Nyland H et al (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9:323-331
20. Bode FJ, Stephan M, Suhling H et al (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17 beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum Mol Genet 17:2595-2609
21. Bostrom I, Stawiarz L, Landtblom AM (2013) Sex ratio of multiple sclerosis in the National Swedish MS register (SMSreg). Mult Scler 19:46-52
22. Bove R, Chitnis T (2013) Sexual disparities in the incidence and course of MS. Clin Immunol 149:201-210 Bronnum-Hansen H, Koch-Henriksen N, Stenager E et al (2004) Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 127:844-850
23. Bruck W, Bitsch A, Kolenda H et al (1997) Inflammatory central nervous system demyelination: correlation with magnetic resonance imaging findings with lesion pathology. Ann Neurol 42:783-793
24. Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93:7861-7864
25. Cappellani R, Bergsland N, Weinstock-Guttman B et al (2014) Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. AJNR Am J Neuroradiol 35:912-919
26. Casiraghi C, Shanina I, Cho S et al (2012) Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis. PLoS Pathog 8(5): e1002715
27. Celius EG, Vandvik B (2001) Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 8:463-469
28. Cerghet M, Skoff RP, Bessert D et al (2006) Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J Neurosci 26:1439-1447
29. Comi G (2013) Disease-modifying treatments for progressive multiple sclerosis. Mult Scler 19:1428-1436
30. Confavreux C, Aimard G, Devic M (1980) Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103:281-300
31. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770-782
32. Correale J, Ysrraelit MC, Gaitan MI (2010) Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185:4948-4958
33. D’Hooghe MB, D’Hooghe T, De Keyser J (2013) Female gender and reproductive factors affecting risk, relapses, and progression in multiple sclerosis. Gynecol Obstet Invest 259:855-861
34. Dahl OP, Aarseth JH, Myrh KM et al (2004) Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 109:378-384
35. Damasceno A, Von Glehn F, Brandao CO et al (2013) Prognostic indicators for long-term disability in multiple sclerosis patients. J Neurol Sci 324:29-33
36. De Stefano N, Matthews PM, Filippi M et al (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60:1157-1162
37. Debouverie M (2009) Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France. J Neurol Sci 286:14-17
38. Debouverie M, Pittion-Vouyovitch S, Louis S et al (2008) Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 15:916-921
39. DeLuca GC, Kimball SM, Kolasinski J et al (2013) Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 39:458-484
40. Du S, Itoh N, Askarinam S et al (2014) Y sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 111:2806-2811
41. Dutta R, McDonough J, Yin X et al (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478-489
42. Elhami SR, Mohammad K, Sahraian MA et al (2011) A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 36:141-147
43. Esparza ML, Sasaki S, Kestelott H (1995) Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 142:733-737
44. Fisher E, Lee JC, Nakamura K et al (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64:255-265
45. Fisniku LK, Chard DT, Jackson JS et al (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64:247-254
46. Fleming J, Fabry Z (2007) The hygiene hypothesis and multiple sclerosis. Ann Neurol 61:85-89
47. Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839-855
48. Ganter P, Prince C, Esiri MM (1999) Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 25:459-467
49. Ghadirian P, Jain M, Ducic S et al (1998) Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 27:845-852
50. Goldschmidt T, Antel J, Konig FB et al (2009) Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72:1914-1921
51. Granieri E, Economou NT, De Gennaro R et al (2007) Multiple sclerosis in the province of Ferrara: evidence for an increasing trend. J Neurol 254:1642-1648
52. Grytten N, Glad SB, Aaeseth JH et al (2006) A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 66:182-186
53. Gur RC, Turetsky BI, Matsui M et al (1999) Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance. J Neurosci 19:4065-4072
54. Hader WJ, Yee IM (2007) Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology 69:1224-1229
55. Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148-152
56. Hedstrom AK, Baarnhielm M, Olsson T et al (2009) Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 73:696-701
57. Hedstrom AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 18:1334-1336
58. Hernan MA, Hohol MJ, Olek MJ et al (2000) Oral contraceptives and the incidence of multiple sclerosis. Neurology 55:848-854
59. Hernan MA, Olek MJ, Ascherio A (2001) Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154:69-74
60. Howell OW, Reeves CA, Nicholas R et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134:2755-2771
61. Irizar H, Munoz-Culla M, Sepulveda L et al (2014) Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression. PLoS ONE 9:e90482
62. Johnson JA, Tough S (2012) Delayed child-bearing. J Obstet Gynaecol Can 34:80-93
63. Kampman MT, Aarseth JH, Grytten N et al (2013) Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. J Neurol 260:1481-1488
64. Kantarci O, Siva A, Eraksoy M et al (1998) Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 51:765-772
65. Kappos L, Moeri D, Radue EW et al (1999) Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or cognitive impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis group. Lancet 353:964-999
66. Khalaj AJ, Yoon J, Nakai J et al (2013) Estrogen receptor (ER) beta expression in oligodendrocytes is required for attenuation of clinical disease by an ERbeta ligand. Proc Natl Acad Sci U S A 110:19125-19130
67. Koch M, Kingwell E, Rieckmann P et al (2010) The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 81:1039-1043
68. Koch-Henriksen N (1999) The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 5:293-296
69. Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520-532
70. Kotzamani D, Panou T, Mastorodemos V et al (2012) Rising incidence of multiple sclerosis in females associated with urbanization. Neurology 78:1728-1735
71. Kuhlmann T, Lingfeld G, Bitsch A et al (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202-2212
72. Kuhlmann T, Goldschmidt T, Antel J et al (2009) Gender differences in the histopathology of MS? J Neurol Sci 286:86-91
73. Kurland LT (1952) Epidemiologic characteristics of multiple sclerosis. Am J Med 12:561-571
74. Kurth F, Luders E, Sicotte NL et al (2014) Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin 4:454-460
75. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
76. Langer-Gould A, Popat RA, Huang SM et al (2006) Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol 63:1686-1691
77. Langer-Gould A, Brara SM, Beaber BE et al (2013) Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 80:548-552
78. Larsen PD, Bloomer LC, Bray PF (1985) Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 35:435-438
79. Lassmann H, van Horssen J (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585:3715-3723
80. Lauer K (1994) The risk of multiple sclerosis in the USA in relation to sociographic features: a factor-analytic study. J Clin Epidemiol 47:43-48
81. Leibowitz U, Kahana E, Alter M (1969) Survival and death in multiple sclerosis. Brain 92:115-130
82. Lemire JM, Archer DC (1996) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental encephalomyelitis. Proc Natl Acad Sci U S A 93:7861-7864
83. Li DK, Held U, Petkau J et al (2006a) MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology 66:1384-1389
84. Li WW, Penderis J, Zhao C et al (2006b) Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS. Exp Neurol 202:250-254
85. Lunemann JD, Jelcic I, Roberts S et al (2008) EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205:1763-1773
86. Luzuriaga K, Sullivan JL (2010) Infectious mononucleosis. N Engl J Med 362:1993-2000
87. Mackenzie IS, Morant SV, Bloomfield GA et al (2014) Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the general practice research database. J Neurol Neurosurg Psychiatry 85:76-84
88. MacKenzie-Graham AJ, Rinek GA, Avedisian A et al (2012) Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis. J Neurosci Res 90:1310-1323
89. Maghzi AH, Ghazavi H, Ahsan M et al (2010) Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 16:359-361
90. Magliozzi R, Howell O, Vora A et al (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089-1104
91. Magliozzi R, Howell OW, Reeves C et al (2010) A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68:477-493
92. Magyari M, Koch-Henriksen N, Pfleger CC et al (2013) Reproduction and the risk of multiple sclerosis. Mult Scler 19:1604-1609
93. Marin-Husstege M, Muggironi M, Raban D et al (2004) Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev Neurosci 26:245-254
94. Matarese G, Procaccini C, De Rosa V (2008) The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis. J Leukoc Biol 84:893-899
95. Mayne CG, Spanier JA, Relland LM et al (2011) 1,25-dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol 41:822-832
96. Mayr WT, Pittock SJ, McClelland RL et al (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 61:1373-1377
97. McAlpine D (1961) The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 84:186-203
98. Midgard R, Riise T, Svanes C et al (1996) Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis. Brain 119:203-211
99. Miller DB, Ali SF, O’Callaghan JP et al (1998) The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann N Y Acad Sci 844:153-165
100. Morales LB, Loo KK, Liu HB et al (2006) Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26:6823-6833
101. Muller R (1947) Studies on disseminated sclerosis. Earlier Invest Acta Med Scand 133:10-37
102. Munger KL, Zhang SM, O’Reilly E et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60-65
103. Munger KL, Levin LI, Hollis BW et al (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832-2838
104. Munger KL, Chitnis T, Ascherio A (2009) Body size and risk of MS in two cohorts of US women. Neurology 73:1543-1550
105. Munger KL, Levin LI, O’Reilly EJ et al (2011) Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 17:1185-1193
106. Munger KL, Bentzen J, Laursen B et al (2013) Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler 19:1323-1329
107. Murray DTJ (2005) Multiple sclerosis: the history of a disease. Demos Medical Publishing, New York
108. Nielsen TR, Pedersen M, Rostgaard K et al (2007) Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals. Mult Scler 13:420-423
109. Nielsen NM, Jorgensen KT, Stenager E et al (2011) Reproductive history and risk of multiple sclerosis. Epidemiology 22:546-552
110. Orton SM, Herrera BM, Yee IM et al (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5:932-936
111. Orton SM, Wald L, Confavreux C et al (2011) Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 76:425-431
112. Pappas RS (2011) Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization. Metallomics 3:1181-1198
113. Patel R, Moore S, Crawford DK et al (2013) Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones. Brain Pathol 23:462-475
114. Patrikios P, Stadelmann C, Kutzelnigg A et al (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129:3165-3172
115. Phadke JG (1987) Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatry 50:523-531
116. Pisitkun P, Deane JA, Difilippantonio MJ et al (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669-1672
117. Ponsonby AL, van der Mei I, Dwyer T et al (2005) Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 293:463-469
118. Ponsonby AL, Lucas RM, van der Mei IA et al (2012) Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 78:867-874
119. Pozzilli C, Tomassini V, Marinelli F et al (2003) ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 10:95-97
120. Precopio ML, Sullivan JL, Willard C et al (2003) Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection. J Immunol 170:2590-2598
121. Pugliatti M, Riise T, Sotgiu MA et al (2005) Increasing incidence of multiple sclerosis in the province of Sassari, northern, Sardinia. Neuroepidemiology 25:129-134
122. Ramagopalan SV, Valdar W, Criscuoli M et al (2009) Age of puberty and the risk of multiple sclerosis: a population based study. Eur J Neurol 16:342-347
123. Ramagopalan SV, Giovannoni G, Yeates DG et al (2013a) Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis. Mult Scler 19:359-361
124. Ramagopalan SV, Lee JD, Yee IM et al (2013b) Association of smoking with risk of multiple sclerosis: a population-based study. J Neurol 260:1778-1781
125. Reynolds R, Roncaroli F, Nicholas R et al (2011) The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol 122:155-170
126. Riccitelli G, Rocca MA, Pagani E et al (2012) Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. Mult Scler 18:1027-1037
127. Riise T, Nortvedt MW, Ascherio A (2003) Smoking is a risk factor for multiple sclerosis. Neurology 61:1122-1124
128. Rojas JI, Patrucco L, Besada C et al (2013) Sex-related differences in atrophy and lesion load in multiple sclerosis patients. Neurologia 28:389-393
129. Roosendaal SD, Bendfeldt K, Vrenken H et al (2011) Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 17:1098-1106
130. Runmarker B, Andersen O (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116:117-134
131. Runmarker B, Andersen O (1995) Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118:253-261
132. Sahraian MA, Radü E-W (2007) MRI Atlas of MS lesions. Springer, Berlin
133. Sanna V, Di Giacomo A, La Cava A et al (2003) Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 111:241-250
134. Savettieri G, Messina D, Andreoli V et al (2004) Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 251:1208-1214
135. Schoonheim MM, Popescu V, Rueda Lopes FC et al (2012a) Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 79:1754-1761
136. Schoonheim MM, Hulst HE, Landi D et al (2012b) Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler 18:164-173
137. Schoonheim MM, Vigeveno RM, Lopes FC et al (2014) Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Brain Mapp 35:2348-2358
138. Schumacher GA (1960) Multiple sclerosis. Postgrad Med 27:569-580
139. Sicotte NL, Liva SM, Klutch R et al (2002) Treatment of multiple sclerosis with the pregnancy hormone estradiol. Ann Neurol 52:421-428
140. Sicotte NL, Giesser BS, Tandon V et al (2007) Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 64:683-688
141. Simpson S Jr, Pittas F, van der Mai I et al (2011) Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951-2009. J Neurol Neurosurg Psychiatry 92:180-187
142. Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175:4119-4126
143. Spence RD, Hamby ME, Umeda E et al (2011) Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci U S A 108:8867-8872
144. Sundstrom P, Nystrom L, Hallmans G (2008) Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 15:579-593
145. Swank RL, Lerstad O, Strom A et al (1951) Multiple sclerosis in rural Norway in geographic and occupational incidence in relation to nutrition. N Engl J Med 246:722-728
146. Taylor LC, Gilmore W, Matsushima GK (2009) SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination. Brain Pathol 19:467-479
147. Tedeschi G, Lavorgna L, Russo P et al (2005) Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 65:280-285
148. Thacker EL, Mirzaei F, Ascherio A (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59:499-503
149. Thompson AJ, Polman CH, Miller DH et al (1997) Primary progressive multiple sclerosis. Brain 120:1085-1096
150. Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105:1296-1299
151. Tiwari-Woodruff S, Morales LB, Lee R et al (2007) Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A 104:14813-14818
152. Tola MR, Graniere E, Malgu S et al (1994) Dietary habits and multiple sclerosis. a retrospective study in Ferrara. Italy. Acta Neurol (Napoli) 16:189-197
153. Tomassini V, Onesti E, Mainero C et al (2005) Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 76:272-275
154. Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8:280-291
155. Trojano M, Lucchese G, Graziano G et al (2012) Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS ONE 7:e48078
156. van der Mei IA, Ponsonby AL, Blizzard L et al (2001) Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20:168-174
157. van Waesberghe JH, van Walderveen MA, Castelijns JA et al (1998) Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Amer J Neuroradiol 19:675-683
158. Van Waesberghe JH, Kamphorst T, De Groot W et al (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747-754
159. van Walderveen MA, Lycklama ANGJ, Ader HJ et al (2001) Hypointense lesions on T1-weighted spin-echomagnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58:76-81
160. Villard-Mackintosh L, Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47:161-168
161. Visser EM, Wilde K, Wilson JF et al (2012) A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry 83:719-724
162. Voskuhl RR, Gold SM (2012) Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 71:129-136
163. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A et al (1996) Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 39:724-733
164. Vukusic S, Confavreux C (2003) Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci 206:135-137
165. Wallin MT, Culpepper WJ, Coffman P et al (2012) The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex, and service. Brain 135:1778-1785
166. Warren SA, Svenson LW, Warren KG (2008) Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Neuroepidemiology 14:872-879
167. Weatherby SJ, Mann CL, Davies MB et al (2000) A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis. J Neurol 247:467-470
168. Weinshenker BG, Rice GP, Noseworthy JH et al (1991) The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114:1045-1056
169. Whitacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2:777-780
170. Woodruff RH, Franklin RJM (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25:216-228
171. Zendedel A, Beyer C, Kipp M (2013) Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci 51:567-575
172. Zhang SM, Willett WC, Hernan MA et al (2000) Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 152:1056-1064
173. Ziehn MO, Avedisian AA, Dervin SM et al (2012a) Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J Neurosci 32:12312-12324
174. Ziehn MO, Avedisian AA, Dervin SM et al (2012b) Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease. Lab Invest 92:1234-1245